Illumina to defend Genome Analyzer System patent infringement suit

Illumina, Inc. (Nasdaq:ILMN) today announced that it has been served with a complaint filed on September 21, 2009 in the U.S. District Court in Wilmington, Delaware naming Illumina as a defendant. The complaint names as plaintiffs Life Technologies Corporation; Applied Biosystems LLC; a Russian research institute; two individuals listed as inventors on the asserted patents; and another individual who appears to have an ownership interest in the patents. The complaint alleges among other things that Illumina’s Genome Analyzer System infringes U.S. Patent Nos. 5,616,478; 5,958,698; and 6,001,568. These patents, which are directed to methods for DNA amplification, expire in 2012 and 2014.

“We will defend this suit vigorously,” said Jay Flatley, President and CEO of Illumina. “We respect the valid and enforceable intellectual property rights of others and, consistent with that policy, we believe that we acted properly with respect to these patents. In the meantime, we will continue to defend and support our customers against Life Technologies’ unfounded claims."

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Illumina, Inc.. (2019, June 19). Illumina to defend Genome Analyzer System patent infringement suit. News-Medical. Retrieved on October 31, 2024 from https://www.news-medical.net/news/20090928/Illumina-to-defend-Genome-Analyzer-System-patent-infringement-suit.aspx.

  • MLA

    Illumina, Inc.. "Illumina to defend Genome Analyzer System patent infringement suit". News-Medical. 31 October 2024. <https://www.news-medical.net/news/20090928/Illumina-to-defend-Genome-Analyzer-System-patent-infringement-suit.aspx>.

  • Chicago

    Illumina, Inc.. "Illumina to defend Genome Analyzer System patent infringement suit". News-Medical. https://www.news-medical.net/news/20090928/Illumina-to-defend-Genome-Analyzer-System-patent-infringement-suit.aspx. (accessed October 31, 2024).

  • Harvard

    Illumina, Inc.. 2019. Illumina to defend Genome Analyzer System patent infringement suit. News-Medical, viewed 31 October 2024, https://www.news-medical.net/news/20090928/Illumina-to-defend-Genome-Analyzer-System-patent-infringement-suit.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Illumina signs initial customer deals for new Global Screening Array